In the U.S. numbers, there certainly could be the start of another inflection. It's unclear, for now. But with J&J doses, plus more Pfizer + Moderna coming online, it's very possible. Watch this angle:
I'd encourage people to look at the rest of our data. At this point, most of the work we put in is collecting international reports (which is much more challenging than in the U.S., now).
Many countries have not had the success that the U.S. has. The EU was just told by AstraZeneca that it won't get its planned supply -- which is a reminder as well of what could quite easily go wrong here, too.
Our methodology blog post also has (from CDC) what the number today *would* have been with a normal pull time. You can find it here (it's still a lot):
⚠️This is a huge number that's 50% bigger than we've ever seen. it's possible there's some sort of data/methodological reason for this. We are investigating and will post a blog/more tweets if we find out something more.
In the meantime, <sportscenter voice> THAT'S A BIG ONE
There are some states here that are all having record days: Take a look at Cali, NY, Mississippi, North Carolina:
⚠️Data note: We made a chance to our NYC methodology that brings it in line with the rest of the U.S. The % of people vaccinated now reflects residents, not place of vaccination. The resulted in a change to our NYC %s.
⭐️Our U.S. 7-day average is now 2.01M doses/day, the first time above 2M. This appears to be driven by a combo of winter-storm make-up doses + increasing supply.
📊1.91M doses today; 7-day 2.01M
🇺🇸US: 80.5M doses total
If there's a significant pull-back after the storm make-up bump, this could slip back down. But between J&J doses going into arms this week + rising shipments of about 15M doses/week, that seems unlikely/short-lived.